Drug Database
Back to search

United States· US:80725-250_4b33337a-4e4b-42f3-923f-5b61f02fc463

Humatin

A paromomycin product containing paromomycin sulfate, registered in United States by Waylis Therapeutics LLC. The same ATC class is registered in 9 of our 19 countries.

ATC A07AA06US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedHumatinATCA07AA06REGISTER NO.US:80725-250_4b33337a…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about paromomycin sulfateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Paromomycin is registered in 9 of 19 countries.

Countries holding a registration under ATC A07AA06 (paromomycin), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 5 of them publish a price we can compare per daily dose
Search paromomycin products by name

Paromomycin · ATC A07AA06

9 / 19 countries

  • Belgiumprice
  • Canada
  • Germany
  • Italyprice
  • Japan
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of paromomycin costs, country by country.

Normalised to the WHO defined daily dose (3 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Paromomycin · price per daily dose (3 g)

USD · FX 28 Sept 2026

  • IT Italy$8.91
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
PAROMOMYCIN SULFATE
Manufacturer
Waylis Therapeutics LLC
Country
United States (US)
ATC code
A07AA06
ATC class
Paromomycin
Defined daily dose
3 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    8072525001
    100 CAPSULE in 1 BOTTLE (80725-250-01)
  • ndc11
    80725-250-01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

35 interactions on record for paromomycin.

Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check paromomycin against other medicinesHow interaction checks work

Paromomycin · interactions on record

35 records

  • 10 severe
  • 23 moderate
  • 2 minor

Most severe, free to view

  • TubocurarineM03AA02severe
  • SuxamethoniumM03AB01severe
  • PancuroniumM03AC01severe
  • VecuroniumM03AC03severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Paromomycin in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All paromomycin products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Austria · Humatin
  • Belgium · Gabbroral
  • Germany · Humatin, Humatin Kapseln
  • Spain · Humatin
  • Italy · Humatin, Kaman
  • Luxembourg · Gabbroral

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/75cf2004-1fec-4219-a643-1faac71035e8
GET /v1/drugs/75cf2004-1fec-4219-a643-1faac71035e8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "250",
  "substance": "PAROMOMYCIN SULFATE",
  "productndc": "80725-250",
  "dosage_form": "CAPSULE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA065173",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about paromomycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console